Thomas Dolca Insider Profile

4 Followers
Thomas Dolca, CMO at Principia Biopharma, holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY), holds 0.00 shares in Principia Biopharma (Ticker: PRNB), holds ― shares in Equillium (Ticker: EQ).
tipranks
Thomas Dolca

Thomas Dolca
Principia Biopharma (PRNB)
CMO

Not Ranked
Thomas Dolca has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Thomas Dolca does not currently own shares as a corporate insider.
A breakdown of Thomas Dolca's holdings

Insider Roles

Equillium
(EQ)
Chief Medical Officer
Allakos
(ALLK)
Director
Roles that Thomas Dolca holds in companies

Most Profitable Insider Trade

Stock:
Chinook Therapeutics
(KDNY)
Rating:Informative Buy
Date:Sep 06, 2022 - Sep 06, 2023
Return:+98.40%
The most profitable trade made by Thomas Dolca

Thomas Dolca's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PRNB
Principia Biopharma
Sep 28, 2020
Uninformative Sell
220.70K
$0.00
KDNY
Chinook Therapeutics
Aug 11, 2023
Uninformative Sell
$0.00
Equillium
Chief Medical Officer
Allakos
Director
List of latest transactions for each holding click on a transaction to see Thomas Dolca's performance on stock

Thomas Dolca insider profile FAQ

What is the percentage of profitable transactions made by Thomas Dolca?
The percentage of profitable transactions made by Thomas Dolca is ―.
    What is the average return per transaction made by Thomas Dolca?
    The average return per transaction made by Thomas Dolca is ―.
      What stocks does Thomas Dolca hold?
      Thomas Dolca holds: PRNB, KDNY, EQ, ALLK stocks.
        What was Thomas Dolca’s latest transaction?
        Thomas Dolca latest transaction was an Uninformative Sell of ―.
          What was Thomas Dolca's most profitable transaction?
          Thomas Dolca’s most profitable transaction was an Informative Buy of KDNY stock on September 6, 2022. The return on the trade was 98.40%.
            What is Thomas Dolca's role in Principia Biopharma?
            Thomas Dolca's role in Principia Biopharma is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.